Newsroom | 5702 results

NEW YORK--(BUSINESS WIRE)--One-Year Follow-up Study Confirms QuantalX’s Delphi-MD Measurements Predict Sustained Response to Ventriculoperitoneal Shunting in NPH...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced financial results for the third quarter ended September 30, 2026, and provided a business update. Joseph DeVivo, Butterfly’s President, Chief Executive Officer and Chairman commented, “Our third quarter results came in ahead of guidance on both revenue and adjusted E...

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the third quarter ("Q3'26"). Commenting on Align's Q3'26 results, Align Technology President and CEO Joe Hogan said, “We delivered solid third-quarter results, with...

ATLANTA--(BUSINESS WIRE)--Focused Cryo completed its first clinical cases with its FDA-cleared directional cryoablation system. All four procedures achieved technical success....

LEBANON, N.H.--(BUSINESS WIRE)--Published pivotal trial data shows lower positive margin rates for Cairn Surgical's Breast Cancer Locator System compared to wire localization in BCS....

ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the third quarter ended September 30, 2026. “Third quarter results showcase quarterly orders performance, an inflection in organic revenue growth, and a doubling of year-to-date adjusted free cash flow generation,” commented Mirion’s Chairman and Chie...

MINNEAPOLIS--(BUSINESS WIRE)--New research published in Clinical Imaging suggests that superior mesenteric artery occlusion (SMAO), a life-threatening vascular emergency requiring rapid diagnosis and treatment, may be overlooked on CT interpretation more often than previously recognized. The findings highlight a significant opportunity for radiologists and radiology practices to strengthen evaluation of the superior mesenteric artery and potentially improve patient outcomes. Conducted by resear...

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, cloud software and AI, today announced that it will attend the UBS Global Healthcare Conference in Palm Beach Garden, FL on November 10, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman and John Doherty, EVP, Chief Financial Officer, will present and host one-on-one investor meetings. The company presentation wil...

ORLANDO, Fla. & LITTLETON, Mass.--(BUSINESS WIRE)--Adults and children facing cancer will have access to more advanced treatment options close to home as the AdventHealth Cancer Institute introduces proton therapy. The MEVION S250-FIT™ Proton Therapy System will expand the care available to Central Floridians. AdventHealth Cancer Institute brings together cancer specialists, advanced treatments, clinical research and services that support patients’ physical, emotional and spiritual needs. Its n...

BOSTON--(BUSINESS WIRE)--Elucid Bioimaging Inc. (“Elucid”) today reaffirmed its commitment to advancing its mission – the prediction and personalization of the prevention of heart attack and stroke – and its confidence in the technology and intellectual property behind its products. Elucid is aware of a lawsuit filed by Heartflow, Inc., on October 22, 2026. Elucid will respond to and defend against the claims in the lawsuit through the appropriate legal channels. “Elucid was founded to help phy...